Ji Hye Choi
Ajou University · 125 works · 2,447 citations · h-index 28
Top works
- Cyclomaltodextrinase, Neopullulanase, and Maltogenic Amylase Are Nearly Indistinguishable from Each Other
- Development of the Internet addiction scale based on the Internet Gaming Disorder criteria suggested in DSM-5
- Single-cell transcriptome profiling of the stepwise progression of head and neck cancer
- Directed Evolution of Thermus Maltogenic Amylase toward Enhanced Thermal Resistance
- The Effect of Depression, Impulsivity, and Resilience on Smartphone Addiction in University Students
- Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer
- A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery
- Disseminated Herpes Zoster in an Immunocompetent Elderly Patient
- Comparison of RECIST and WHO response criteria in metastatic colorectal carcinoma
- Gold-based hybrid nanomaterials for biosensing and molecular diagnostic applications
- Keratin 19 Expression in Hepatocellular Carcinoma Is Regulated by Fibroblast-Derived HGF via a MET-ERK1/2-AP1 and SP1 Axis
- Orientia tsutsugamushi Subverts Dendritic Cell Functions by Escaping from Autophagy and Impairing Their Migration
- Absence of Autophagy-Related Proteins Expression Is Associated with Poor Prognosis in Patients with Colorectal Adenocarcinoma
- EUKARYOME: the rRNA gene reference database for identification of all eukaryotes
- Active Escape of Orientia tsutsugamushi from Cellular Autophagy
- Sweetness potency and sweetness synergism of sweeteners in milk and coffee systems
- 1377P Exploratory analyses of efficacy from a phase III study comparing SB8, a proposed bevacizumab biosimilar, and reference bevacizumab in patients with metastatic or recurrent non-squamous NSCLC
- Effects of Gaseous Ozone Exposure on Bacterial Counts and Oxidative Properties in Chicken and Duck Breast Meat
- A phase III, randomized, double-blind, multicenter study to compare the efficacy, safety, pharmacokinetics, and immunogenicity between SB8 (proposed bevacizumab biosimilar) and reference bevacizumab in patients with metastatic or recurrent nonsquamous non-small cell lung cancer
- Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis